PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.\', \'Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.\', \'Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.\', \'Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.\', \'Department of Neurology, Amsterdam Neuroscience Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.\', \'Division of Clinical Pharmacology, University of Kansas Medical Center, Kansas City, KS, USA.\', \'Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA.\', \'Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: e.s.stroes@amsterdamumc.nl.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0021-9150(21)01503-310.1016/j.atherosclerosis.2021.12.008
?:doi
?:hasPublicationType
?:journal
  • Atherosclerosis
is ?:pmid of
?:pmid
?:pmid
  • 34995986
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.967
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all